EGB Stock Chart & Stats
€154.85
€11.60(7.83%)
At close: 4:00 PM EDT
€154.85
€11.60(7.83%)
Day’s Range― - ―
52-Week Range€125.70 - €184.00
Previous CloseN/A
Volume135.00
Average Volume (3M)3.00
Market Cap
€9.63B
Enterprise Value€12.10B
Total Cash (Recent Filing)€391.69M
Total Debt (Recent Filing)€2.29B
Price to Earnings (P/E)26.6
Beta0.04
Next Earnings
Feb 10, 2027EPS Estimate
1.9Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)6.91
Shares Outstanding58,282,433
10 Day Avg. Volume9
30 Day Avg. Volume3
Financial Highlights & Ratios
PEG Ratio2.06
Price to Book (P/B)4.47
Price to Sales (P/S)1.97
P/FCF Ratio26.93
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€197.76Price Target Upside27.71% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)6.96
Revenue Forecast (FY)€5.26B
Bulls Say, Bears Say
Bulls Say
Revenue And Cash-flow GrowthSustained revenue expansion alongside strong free cash flow indicates that growth is translating into internally generated capital. This supports reinvestment in facilities, technology, and acquisitions while reducing reliance on external financing over the next several quarters.
Clinical Quality And OccupancyHigh quality ratings and above-peer clinical outcomes can strengthen relationships with hospitals, managed-care plans, patients, and referral sources. Occupancy below mature-facility levels also leaves a credible organic growth runway if execution remains consistent.
Liquidity Supports ExpansionA substantial liquidity position gives Ensign flexibility to fund acquisitions and capital investments without immediately depending on volatile capital markets. This financial capacity can help the company compete for assets and sustain its expansion strategy.
Bears Say
Recent Margin PressureRecent gross and operating margin compression suggests that revenue growth is facing cost or mix pressure. If the trend persists, it could limit earnings conversion, reduce the cash available for reinvestment, and make future growth less profitable.
Challenged New AcquisitionsTurnaround acquisitions can broaden the platform, but underperforming facilities require management attention and investment before they contribute meaningfully. Florida and Texas therefore create execution risk and may weigh on consolidated results during the improvement period.
Leverage VolatilityAlthough leverage improved in the latest period, the sharp historical swings indicate that acquisition financing and capital structure decisions can materially change balance-sheet risk. Repeated increases could constrain flexibility and raise the burden of future expansion.
EGB FAQ
What was The Ensign Group’s price range in the past 12 months?
The Ensign Group lowest stock price was €125.70 and its highest was €184.00 in the past 12 months.
What is The Ensign Group’s market cap?
The Ensign Group’s market cap is €9.63B.
When is The Ensign Group’s upcoming earnings report date?
The Ensign Group’s upcoming earnings report date is Feb 10, 2027 which is in 104 days.
How were The Ensign Group’s earnings last quarter?
The Ensign Group released its earnings results on Oct 27, 2026. The company reported €1.825 earnings per share for the quarter, beating the consensus estimate of €1.77 by €0.055.
Is The Ensign Group overvalued?
According to Wall Street analysts The Ensign Group’s price is currently Undervalued.
Does The Ensign Group pay dividends?
The Ensign Group does not currently pay dividends.
What is The Ensign Group’s EPS estimate?
The Ensign Group’s EPS estimate is 1.9.
How many shares outstanding does The Ensign Group have?
The Ensign Group has 58,282,433 shares outstanding.
What happened to The Ensign Group’s price movement after its last earnings report?
The Ensign Group reported an EPS of €1.825 in its last earnings report, beating expectations of €1.77. Following the earnings report the stock price went up 9.222%.
Which hedge fund is a major shareholder of The Ensign Group?
Currently, no hedge funds are holding shares in DE:EGB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
The Ensign Group Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€197.76 (27.71% Upside)
€197.76 (27.71% Upside)
Blogger Sentiment
Bullish
DE:EGB Sentiment 75%
Sector Average 65%
Sector Average 65%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-8.98%
12-Months-Change
Fundamentals
Return on Equity
16.63%
Trailing 12-Months
Asset Growth
16.61%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
The Ensign Group
The Ensign Group, Inc. operates as a healthcare provider, primarily concentrating on post-acute care services, alongside other supporting business ventures. The company's activities are organized into two main divisions: Skilled Services and Real Estate. Within its Skilled Services segment, Ensign provides extensive short-term and long-term nursing care tailored for patients recovering from extended illnesses, managing chronic health conditions, or requiring elder care. This division also encompasses a variety of rehabilitative therapies, such as physical, occupational, and speech therapy, among other specialized healthcare provisions. Beyond direct medical care, the company furnishes essential amenities like lodging, customized dietary programs, and opportunities for social engagement, recreation, and entertainment. Ensign additionally manages senior living facilities and delivers convenient mobile diagnostic services. Its diverse array of supplementary services includes digital X-rays, ultrasounds, electrocardiograms, laboratory analyses, sub-acute care, and patient transportation, which can be provided either in patients' residences or at long-term care facilities. The company also engages in the leasing of real estate properties. As of April 4, 2022, Ensign operated a network of 252 healthcare facilities spread across thirteen U.S. states: Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. The Ensign Group, Inc. was established in 1999 and is headquartered in San Juan Capistrano, California.
EGB Company Deck
EGB Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was strongly positive, supported by double-digit revenue and earnings growth, higher 2026 guidance, broad-based occupancy and skilled-mix gains, above-market clinical outcomes, substantial acquisition activity, and significant balance-sheet capacity. Management also highlighted ongoing AI and technology investments and a large acquisition pipeline. The main challenges were concentrated in newly acquired turnaround operations, particularly in Florida and Texas, which have below-average occupancy, clinical, financial, and physical-plant issues and are expected to take a year or more to contribute. Overall, the highlights significantly outweighed the lowlights.View all DE:EGB earnings summariesEGB Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
€197.76
▲(27.71% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Addus Homecare
―
Brookdale Senior Living
―
National Healthcare
―
Pennant Group
―
PACS Group Inc
―








